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Summary. Background: Venous thrombosis is common in
the older population. Assessment of risk factors is neces-
sary to implement preventive measures. Objectives: We
studied the associations between immobility-related risk
factors and thrombosis, specifically, hospitalization, sur-
gery, fractures, plaster cast use, minor injuries, and tran-
sient immobility at home, in an older population. Patients
and Methods: Analyses were performed in the Age and
Thrombosis, Acquired and Genetic risk factors in the
Elderly (AT-AGE) study, a two-center population-based
case-control study. Consecutive cases aged > 70 years
with a first-time thrombosis (n = 401) and control sub-
jects > 70 years old without a history of thrombosis
(n = 431) were included. Exclusion criteria were active
malignancy and severe cognitive disorders. We calculated
odds ratios (OR) with 95% confidence intervals (95% CI)
after adjustment for age, sex, body mass index, study cen-
ter, and population-attributable risks. Results: There was
a 15-fold (OR 14.8, 95% CI 4.4–50.4) increased risk of
thrombosis within 2 weeks after hospital discharge. Sur-
gery (OR 6.6, 95% CI 3.7–11.6), fractures (OR 12.7, 95%
CI 3.7–43.7), plaster cast (OR 6.2, 95% CI 2.0–18.9),
minor leg injuries (OR 1.9, 95% CI 1.1–3.3), and tran-
sient immobility at home (OR 5.0, 95% CI 2.3–11.2) were
all associated with thrombosis risk over 3 months. The
population-attributable risks for in-hospital immobility
was 27%, and for out-of-hospital immobility, 15%. Con-
clusions: In those > 70 years of age, in-hospital and out-
of hospital immobility are strong risk factors for throm-
bosis. Additional studies on preventive measures during
immobilization in this age group should not focus solely
on hospital settings.
Keywords: aged; immobilization; population at risk; pul-
monary embolism; risk factors; venous thrombosis.
Introduction
Venous thrombosis presents mainly as deep venous
thrombosis of the leg (DVT) and pulmonary embolism
(PE). The incidence of thrombosis increases sharply with
age, being rare in young individuals (< 1 per 10 000 per
year) and increasing to approximately 1% per year in
very old age [1]. More than two-thirds of all patients with
venous thrombosis are aged ≥ 60 years, and 25% are
older than 80 years [2]. So, increasing age is one of the
most important risk factors. As venous thrombosis is a
potentially lethal disease, morbidity (e.g. the postthrom-
botic syndrome) is common, and treatment has frequent
side effects, prevention efforts will have large effects in
older individuals [3]. However, the risk factors for throm-
bosis in the older population are not well characterized
since studies to date mainly included young and middle-
aged individuals [4].
Immobility is associated with reduced venous blood
flow, particularly in the pockets of the venous valves,
leading to inflammation and hypercoagulability [5,6]. In
young and middle-aged individuals, immobility, such as
that due to hospitalization or minor injuries, is an estab-
lished risk factor for thrombosis with relative risk esti-
mates ranging from 3 to 11 [7,8]. However, it is unknown
to what extent immobilization increases the risk of venous
thrombosis in older individuals. We hypothesized that
immobility-related risk factors would be strong risk fac-
tors in this population.
The aim of this study was to assess the risk of venous
thrombosis associated with hospitalization, surgery, use of
a plaster cast, minor injury, and transient immobility at
home in a case–control study of people aged ≥ 70 years.
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Methods
Identification of participants
The Age and Thrombosis, Acquired and Genetic risk fac-
tors in the Elderly (AT-AGE) Study is a two-center, pop-
ulation-based case–control study in Leiden, the
Netherlands, and Burlington, VT, USA, designed to study
risk factors for venous thrombosis in the older popula-
tion. From June 2008 to August 2011 in Leiden and
December 2008 to July 2011 in Burlington, all consecutive
patients aged ≥70 years with DVT or PE were identified.
In Leiden, cases were identified from two anticoagula-
tion clinics in a defined geographical area in the western
part of the Netherlands. In Burlington, cases were identi-
fied in the Vascular Laboratory and the Radiology
Department of Fletcher Allen Health Care, Burlington,
VT, which are the only diagnostic centers in that geo-
graphic area. We defined venous thrombosis as DVT
alone or PE with or without a proven DVT by ultrasound
(PE with or without DVT). We were unable to accurately
define isolated PE without DVT since diagnostic measures
of thrombosis of the legs are not routinely performed in
all PE patients. Control subjects were identified in Leiden
and Burlington in the same geographic area as the cases.
Control subjects were randomly selected from five pri-
mary care practices in Leiden and four in Burlington.
All identified cases and control subjects were mailed an
invitation letter, followed by a telephone call to discuss
participation. Individuals were excluded from participa-
tion if they responded affirmatively that they had an
active malignancy, defined as diagnosis of cancer within
6 months before the thrombotic event (or date of tele-
phone call for the control subjects) or chemotherapy or
radiation therapy for cancer in the past 6 months. Poten-
tial participants with severe psychiatric or cognitive disor-
der, as judged by the telephone contact, were excluded.
We also excluded individuals who self-reported previous
DVT or PE within the past 10 years.
Of the 1187 identified cases, 689 (58%) were eligible
and 498 (42%) were excluded. (Fig. 1) Of those excluded,
55 (11%) died before inclusion was possible, 159 (32%)
had active malignancy, 108 (22%) had an apparent severe
cognitive or psychiatric disorder, and 171 (34%) had a
history of venous thrombosis within the past 10 years. Of
the 723 identified control subjects, 631 (87%) were eligible
and 92 (13%) were excluded: 15 (16%) died before inclu-
sion was possible, 19 (21%) had active malignancy, 34
(37%) had an apparent severe cognitive or psychiatric
disorder, and 10 (11%) had a history of venous thrombo-
sis within the past 10 years (see Fig. S1 for participation
flowchart by study center).
All participants provided written informed consent in
accordance with the Declaration of Helsinki and gave
permission to obtain information about their medical his-
tory. The study was approved by the Medical Ethical
Committee of the Leiden University Medical Center and
by the Committee of Human Research of the University
of Vermont.
Data collection
In Leiden, 398 (71%) of the 561 invited cases and 321
(76%) of the 422 invited control subjects participated. In
Burlington, 128 cases were invited and 75 (59%) partici-
pated, while 140 (67%) of the 209 invited control subjects
participated. For all eligible cases and controls subjects
who agreed to participate, home visits were scheduled.
During this home visit, an extensive structured interview
and blood collection were completed by trained person-
nel. The index date was defined as the date of diagnosis
of the thrombosis for the cases and the date of the in-
home interview for the control subjects.
The interview assessed thrombosis risk factors that
have been established in the young and middle-aged as
well as other putative age-specific risk factors that were
present within 3 months of the index date. Questions que-
ried hospitalizations, surgery during hospitalization, frac-
tures and use of plaster cast (or splint), minor injuries of
the lower extremities, and transient immobility at home,
including dates and location. Physical measurements were
performed including weight (measured with a calibrated
scale) and height. Body mass index (BMI) was calculated
by dividing body weight (kg) by height squared (m2).
Analyses
For these analyses on the etiology of thrombosis, we
included only cases and control subjects without a history
of venous thrombosis (403 cases and 433 control subjects)
who had complete interview data (401 cases and 431 con-
trol subjects). Characteristics of the control subjects
included in Leiden and in Burlington were analyzed sepa-
rately to provide insight into the source populations. For
all further analyses, we combined data from the two sites.
We determined associations between transient immobil-
ity–related risk factors and venous thrombosis. Transient
immobility was defined as a status of immobility that is
shortly present in one’s life. As estimates of relative risk,
we calculated odds ratios (OR) and their 95% confidence
intervals (95% CI) using logistic regression models. All
reported ORs were adjusted for age (continuous), sex,
BMI (continuous), and study center using multivariable
logistic regression analysis. Stratified analyses were per-
formed for DVT and for PE with or without DVT.
Hospitalization was defined as present when the partici-
pant was hospitalized at the index date or the discharge
date was within the 3-month window previous to the
index date. Hospital admission for both inpatients and
day patients were taken into account. Hospitalization for
surgical and nonsurgical indications was analyzed sepa-
rately. The presence of a fracture or plaster cast (or
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splint) in the 3 months before the index date were ana-
lyzed as putative risk factors, as were minor injuries of
the lower extremities and transient immobility at home. A
minor injury was defined as an injury of the lower
extremities (hip, knee, ankle, or foot) such as a sprained
ankle or contusion of the lower leg that started within the
3-month window. A period of transient immobility at
home was defined as a period of ≥ 4 consecutive days of
immobility, such as being bedridden or continuously sit-
ting in a chair, that started within the 3 months before
the index date. If participants were bed- or chair-ridden
for the entire 3 months before the index date, they were
classified as chronically immobilized and not included in
the analyses.
To study the duration of risk of venous thrombosis
after the transient risk factor, we dichotomized the time
between the risk factor and venous thrombosis by the
median time from the end of the risk period (for hospital-
ization) or the start of the risk period (for minor injury
or transient immobility at home) in the control subjects.
Since the group of participants with hospitalization in the
3 months before the index date was large enough for fur-
ther stratification, to study the time trend in risk of
venous thrombosis in more detail, the time after hospital
discharge was divided into three periods (< 2 weeks,
2–4 weeks, and 4 weeks–3 months). The small number of
control subjects with fractures or plaster cast prohibited a
detailed analysis of the risk by time from immobilization.
In addition, a sensitivity analysis was performed. Since
the index date was defined as the date of the home visit
for the control subjects and therefore, per definition, none
of the controls were hospitalized on the index date,
assessment of the risk of thrombosis during hospitaliza-
tion was not directly possible. To estimate the risk of
venous thrombosis during hospitalization, the index date
of the controls was moved back by 5 weeks (i.e. by the
median time [in weeks] of the cases between diagnosis of
thrombosis and home visit).
We calculated population attributable risk (PAR) as:
pd(OR – 1)/(OR), in which pd is the proportion of cases
exposed to the risk factor of interest. In this case, the
PAR indicates the proportion of the total incidence of
venous thrombosis in those ≥ 70 years old who were eligi-
ble for this study that can be attributed to the risk factor
of interest [9,10]. We calculated the PAR for all immobil-
ity-related risk factors combined and for in-hospital and
out-of-hospital immobility, separately. Out-of-hospital
immobility was defined as the presence of fractures, plas-
ter cast (or splint), minor injuries, and transient immobil-







Cases visited  
498 (42%) Excluded
171    VT < 10 years ago
159    Active malignancy 
108    Cognitive decline 
  55    Died
    5    Different reason 
216 (32%) No participation
  58   Illness 
153   No time 
     5   Not able to reach
403 (85%)
Cases
without VT history  
70 (15%)
Cases
VT history >10 years ago   
AT-AGE Control Subjects
723




Control Subjects visited 
92 (13%) Excluded
10    VT < 10 years ago
19    Active malignancy 
34    Cognitive decline 
15    Died
14    Different reason 
170 (27%) No participation
  25   Illness 
135   No time 
  10   Not able to reach
433 (94%)
Control Subjects
without VT history 
28 (6%)
Control Subjects
VT history >10 years ago
Fig. 1. Flowchart of AT-AGE study.
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Results
For the cases, the median duration between the index
date and the home visit was 5 weeks (range 1–44 weeks),
75% were visited within 7 weeks, and 90% were visited
within 10 weeks. General characteristics of the control
subjects in Leiden and Burlington are shown in Table 1.
In both centers, ~30% of the control subjects were ≥
80 years old. Median BMI was slightly higher in Burling-
ton than in Leiden. Of the 401 cases, in Leiden, 134
(39%) of the cases had DVT, and 207 (61%) had PE with
or without DVT, and in Burlington, 32 (53%) had DVT
and 28 (47%) had PE with or without DVT. In 155 of
the 166 DVT cases (93%) and in 220 of the 235 PE cases
(94%), we were able to obtain the diagnostic report of
the thrombotic event and thrombosis was thus objectively
confirmed via ultrasound and PE was confirmed via spiral
computed tomography or ventilation-perfusion lung scan.
Table 2 shows the risk of venous thrombosis associated
with immobility-related risk factors. Overall, hospitaliza-
tion was associated with a greater than 7-fold increased
risk of venous thrombosis (OR 7.2, 95% CI 4.5–11.4).
Among cases and controls with hospitalization, the median
duration of hospital stay in the cases was 10 days (range 2–
55 days), and in the control subjects, 3 days (range 1–22
days). Dichotomization of the time between discharge from
hospital and the index date, based on the median time of
hospitalization until the index date in the control subject
(48 days, range 4–89), showed that the risk of venous
thrombosis was 7.9-fold increased in the first 7 weeks after
discharge (OR 7.9, 95% CI 4.2–14.7) and 2.1-fold
increased after 7 weeks (7 weeks–3 months, OR 2.1, 95%
CI 1.0–4.4). Further stratification of the time between hos-
pital discharge and the index date showed a 14.8-fold
increased risk of thrombosis within the first 2 weeks after
discharge from the hospital (OR 14.8, 95% CI 4.4–50.4)
and gradually decreasing risk to a 3-fold increased risk
between 2 weeks and 3 months after discharge (Table 3).
Performing a sensitivity analysis using the recalculated
index date for the controls, 41 (10.1%) cases and 1 (0.2%)
control subject were hospitalized during the index date,
indicating that the thrombotic risk was highest during hos-
pitalization, although the CI was wide (OR 48.7, 95% CI
6.6–361.0).
Among the cases hospitalized within the 3 months
before the index date, 79 of the 126 (63%) had surgery
during the hospital admission. When compared with indi-
viduals without hospitalization, the risk of venous throm-
bosis associated with surgery-related hospitalizations (OR
6.6, 95% CI 3.7–11.6) was similar to that for non–sur-
gery-related hospitalizations (OR 5.5 95% CI 2.7–10.4,
OR for surgical versus nonsurgical admission 1.1, 95%
CI 0.4–2.7). Thirty-one (7.8%) of the cases and 4 (0.9%)
of the control subjects underwent lower extremity surgery,
indicating that lower extremity surgery was associated
with an almost 9-fold increased risk of thrombosis
(OR 8.6, 95% CI 3.0–25.1).
Fracture was associated with a nearly 13-fold increased
risk of thrombosis (OR 12.7, 95% CI 3.7–43.7). In the
cases, two-thirds of fractures (n = 17) were of the lower
extremities; of these patients, eight (47%) presented with
a DVT. In 87% of these cases, the DVT was diagnosed
on the ipsilateral side as the fracture. Use of a plaster cast
or a splint was associated with a 6-fold increased risk of
thrombosis (OR 6.2, 95% CI 2.0–18.9).
Minor leg injury was associated with a 1.9-fold
increased risk of thrombosis (OR 1.9, 95% CI 1.1–3.3).
The median time of occurrence of the minor injury until
the index date was 43 days (range 1–92) for the cases and
27 days (range 4–93) for the controls. Compared with
individuals without a minor injury in the 3 months before
the index date, the risk of venous thrombosis was 1.3-fold
(95% CI 0.6–2.7) increased in the first 4 weeks after start
of the minor injury and remained 2.8-fold (95% CI 1.3–
5.8) increased between 4 weeks and 3 months after the
start of the immobility. The risk of thrombosis was
increased in individuals with sprains of the ankle or knee
(OR 1.9, 95% CI 0.6–6.1) and a contusion of the leg (OR
1.5, 95% CI 0.7–3.1). In 24 of the 41 cases (59%) with a
minor injury, a DVT was diagnosed, while 17 cases
(41%) had PE with or without DVT. In 22 of these 24
cases (92%), the DVT was diagnosed on the ipsilateral
side as the minor injury.
Transient immobilization was associated with a 5-fold
increased risk of thrombosis (OR 5.0, 95% CI 2.3–11.2).





No. of participants 306 125
Median age, n (range) 76 (70–94) 76 (70–96)
70–75 years, n (%) 126 (41) 49 (39)
75–80 years, n (%) 90 (29) 39 (31)
80–85 years, n (%) 61 (20) 24 (19)
> 85 years, n (%) 29 (10) 13 (11)
Men, n (%) 147 (48) 62 (50)
Ethnicity white, n (%)* 284 (93) 124 (99)
Smoking status*
Never, n (%) 88 (29) 32 (26)
Former, n (%) 168 (55) 87 (69)
Current, n (%) 49 (16) 6 (5)
Median BMI
(kg m2) (range)*
25.9 (17.0–42.0) 27.3 (19.0–49.7)
Hospitalization, n (%)† 16 (5) 13 (10)
Surgery, n (%)† 12 (4) 4 (3)
Fracture, n (%)† 1 (0.3) 2 (2)
Plaster cast (splint), n (%)† 2 (1) 2 (2)
Minor injury, n (%)*† 18 (6) 8 (7)
Transient immobility
at home, n (%)*†
5 (2) 3 (2)
BMI, body mass index. *Ethnicity 5 missing values, smoking 1 miss-
ing value, BMI 8 missing values, minor injury 1 missing value, tran-
sient immobility at home 1 missing value. †Less than 3 months
before index date.
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Median duration of transient immobilization at home was
8 days (range 4–77 days) in the cases and 10 days (range
4–30 days) in control subjects. The median time of the
start of transient immobility until the index date was
27 days (range 2–81) for the cases and 63 days (range 38–
86) for the control subjects. The risk of thrombosis was
7.7-fold increased (95% CI 2.6–22.9) within the first
9 weeks (63 days) after the transient immobility, whereas
as an OR of 2.5 (95% CI 0.8–8.5) was found if transient
immobility was > 9 weeks up to 3 months earlier. In 42%
of the cases, the reason for transient immobilization at
home was an infection, 23% had generalized weakness or
‘malaise,’ 17% had fracture, and 9% each had back pain
or a minor injury. Of the cases, 5 (1.2%) were chronically
immobilized, whereas none of the control subjects were
chronically immobilized.
All immobility risk factors were similarly associated
with both DVT and PE with or without DVT. (Table 3)
Overall, immobilization from any cause had a PAR of
39%. In-hospital immobility and out-of-hospital immobil-
ity had PARs of 27% and 15%, respectively.
Discussion
In the AT-AGE study, a case–control study on venous
thrombosis risk in people aged ≥ 70 years, we determined
that immobility-related risk factors (i.e. hospitalization,
surgery, fractures, plaster cast [or splint], minor injuries
of the legs, and transient immobility at home) were
strongly associated with the risk of venous thrombosis
(both DVT and PE with or without DVT) in the
3 months after the start of the immobility (OR 2–13).
The highest risk of thrombosis was for found for immobi-
lization during hospitalization (OR 48.7, 95% CI 6.6–
361.0), and the risk of thrombosis out-of hospital was
15-fold increased within the 2 weeks after hospital dis-
charge; the risk remained increased for 3 months after
hospital discharge. Predefined potential confounders of
the risk factors (i.e. age, sex, BMI, and study center) did
not alter any of the associations. Previous studies on
immobility and the risk of thrombosis in older popula-
tions reported similar risk estimates, ranging from 1.5- up
to > 8-fold increased risks. [4] Based on the PARs we









Hospitalization, n (%)† 126 (31.4) 29 (6.7) 6.4 (4.1–9.8) 7.2 (4.5–11.4)
Surgery, n (%)† 79 (19.7) 16 (3.7) 6.4 (3.6–11.1) 6.6 (3.7–11.6)
Thrombosis after discharge, n (%) 84 (67)
Time after discharge‡
< 2 weeks (%) 28 (9.3) 3 (0.7) 13.6 (4.1–45.3) 14.8 (4.4–50.4)
2–4 weeks (%) 17 (5.9) 3 (0.7) 8.3 (2.4–28.5) 8.8 (2.5–31.5)
> 4 weeks–3 months (%) 38 (12.1) 22 (5.2) 2.5 (1.5–4.4) 2.9 (1.6–5.1)
Fracture, n (%)† 27 (6.7) 3 (0.7) 10.3 (3.1–34.2) 12.7 (3.7–43.7)
Plaster cast (splint), n (%)† 21 (5.2) 4 (0.9) 5.9 (2.0–17.3) 6.2 (2.0–18.9)
Minor injury, n (%)†‡ 41 (10.5) 26 (6.1) 1.8 (1.1–3.0) 1.9 (1.1–3.3)
Start of minor injury (approximately)
< 4 weeks (%) 15 (4.1) 15 (3.6) 1.1 (0.6–2.4) 1.3 (0.6–2.7)
> 4 weeks–3 months (%) 26 (6.9) 11 (2.7) 2.7 (1.3–5.6) 2.8 (1.3–5.8)
Transient immobility at home, n (%)†‡ 34 (8.8) 8 (1.9) 5.1 (2.3–11.1) 5.0 (2.3–11.2)
Start of transient immobility‡
< 9 weeks (%) 25 (6.6) 4 (0.9) 7.5 (2.6–21.7) 7.7 (2.6–22.9)
> 9 weeks–3 months (%) 9 (2.5) 4 (0.9) 2.7 (0.8–8.8) 2.5 (0.8–8.5)
OR, odds ratio, CI, confidence interval. *Adjusted for age (continuous), sex, body mass index (continuous), and study center. †Less than 3
months before index date. ‡Time after discharge: cases: 1 missing value, control subject 1 missing value; minor injury 6 missing values, tran-
sient immobility at home: 6 missing values.
Table 3 ORs of thrombosis over 3 months with transient immobility risk factors stratified by type of thrombosis
Exposure N, DVT/total VT (%) DVT, OR (95% CI)* PE with or without DVT, OR (95% CI)*
Hospitalization 43/126 (34) 5.6 (3.2–9.8) 9.1 (5.5–15.2)
Surgery 27/79 (34) 5.3 (2.7–10.4) 7.9 (4.2–14.6)
Fracture 11/27 (41) 14.2 (3.7–55.3) 10.9 (2.9–40.5)
Plaster cast (splint) 6/21 (29) 4.2 (1.1–16.5) 7.6 (2.3–24.9)
Minor injury 24/41 (59) 2.6 (1.4–4.9) 1.4 (0.7–2.6)
Transient immobility at home 7/34 (21) 2.4 (0.8–6.8) 7.4 (3.2–17.2)
OR, odds ratio; DVT, deep venous thrombosis of the leg; VT, venous thrombosis; PE, pulmonary embolism; CI, confidence interval. *Adjusted
for age (continuous), sex, body mass index (continuous), and study center.
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observed, the overall contribution of immobility to
thrombotic risk (both in and out of hospital) in this study
population was 40%. A PAR of 27% was found for in-
hospital–related immobility. This contrasts with data pre-
viously reported for younger people, where the PAR was
only 15% for hospital-related immobility [4]. Importantly,
the PAR was 15% for out-of-hospital immobility in the
past 3 months in this older population. These findings
indicate that immobility explains part of the age gradient
in the incidence of venous thrombosis.
Findings illustrate the large impact of immobility, a
common occurrence in the older population. The preva-
lence of immobility-related risk factors in the 3 months
before the index date for our control group ranged from
2% to 8% for the different exposures.
Hospitalization causes immobilization [11]. In line with
this, we found that cases were hospitalized for a longer
period than the control subjects. One should take into
account that severity and disease entity during hospital-
ization can influence the risk of thrombosis, as can the
duration of hospitalization [12].
As in a younger population, we found that minor
injuries were associated with a higher risk of thrombosis
over 3 months [8]. For minor injury, the time of highest
risk differed than for other types of immobility, with a
higher risk after 4 weeks compared with shortly after
the minor injury. For the other studied factors, the risk
was highest shortly after the exposure of immobility. It
is possible that the seriousness of the minor injury, and
the long-term consequences, influence the degree of
immobility and increase the thrombotic risk, rather than
the minor injury itself. It is also possible that this find-
ing was a chance finding. Transient immobilization at
home increased the risk of thrombosis 5-fold, and this
risk was highest in the first 2 months after immobiliza-
tion. Transient immobilization at home was most fre-
quently due to infection, an important trigger for
thrombosis [13].
The increased risk of thrombosis associated with out-
of-hospital immobility indicates that prophylaxis may be
beneficial. Home treatment with prophylaxis has effec-
tively been implemented in other high-risk groups, such
as orthopedic surgical patients [14]. The EXtended CLini-
cal prophylaxis in Acutely Ill Medical patients
(EXCLAIM) trial showed a beneficial effect of a longer
duration of treatment within the older population
(> 75 years) [15]. However, in two clinical trials including
inpatients, extended thromboprophylaxis after discharge
reduced thrombosis rates at the cost of higher bleeding
rates (30-day event rate: 0.5%–0.8%) [16,17]. Other pre-
ventive measures that might be considered in this high-
risk group include the use of graded elastic compression
stockings or aspirin [18,19].
Recruiting older individuals in research is challenging
[20]. We overcame this by performing home visits to
assess the presence of risk factors. This enabled us to
recruit less mobile individuals and achieve a high partic-
ipation rate (participation rate: cases 68%, control sub-
jects 73%). As in any case–control study, recall bias
might have occurred. However, both cases and controls
were interviewed by trained personnel using a standard-
ized interview, which minimizes the risk of bias. Using
an interview for assessment of risk factors for thrombo-
sis within 3 months before the index date enabled us to
determine putative risk factors, such as transient immo-
bility at home, that might be challenging to determine
(e.g. these are not mentioned regularly in medical
reports and they might be difficult to recall precisely
after a longer period). Unfortunately, data on preventive
measures in the hospital (e.g. low molecular heparin
injections) were not collected. However, individuals with
in-hospital immobilization were most likely more often
treated with thromboprophylaxis as their risk of venous
thrombosis is thought to be increased. More frequent
treatment with thromboprophylaxis in immobilized indi-
viduals, compared with individuals who are not immobi-
lized, leads to an underestimation of the true relative
risk of venous thrombosis associated with in-hospital
immobilization.
In a case–control study, associations may be biased if
the willingness to participate is affected by the presence
of the risk factor. We minimized this bias by performing
home visits and achieving a high participation.
Moreover, the sensitivity analysis in which we recalcu-
lated the index date of the control subjects did not alter
interpretations of our results. We excluded cancer patients
so our results are not generalizable to these individuals.
Finally, a number of potential participants died before
they could be invited to participate. The impact on our
results is difficult to determine, but these participants
were more likely to be immobilized, resulting in an under-
estimation of the true risk.
In conclusion, the contribution of immobility-related
risk factors, defined as hospitalization, fracture, plaster
cast (or splint), minor injury of the leg, and transient
immobilization at home, to the risk of venous thrombosis
in the older population is high. Studies regarding preven-
tive measures during immobilization should focus on both
in-hospital and out-of-hospital patients.
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